4Weber S, Gribouval O, Esquivel EL, et al. NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int, 2004,66 :571-579.
5Caridi G, Berdeli A, Dagnino M, et al. Infantile steroid-resistantnephrotic syndrome associated with double homozygous mutations of podocin. Am J Kidney Dis, 2004, 43: 727-732.
6Fuchshuber A, Jean G, Gribouval O, et al. Mapping a gene(SRNI) to chromosome 1q25-q31 in idiopathic nephrotic syndrome cortfirms a distinct entity of autosomal recessive nephrosis. Hum Mol Genet, 1995, 4 : 2155-2158.
7Katie SM, Uetz B, Ronner V, et al. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Sec Nephrol ,2002, 13: 388-393.
8Caridi G, Bertelli R, C-arrea A, et al. Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroidresistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol ,2001, 12: 2742-2746.
9Ruf RG, Lichtenberger A, Katie SM, et al. Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol, 2004,15:722-732.
10Boute N, Gribouval O, Roselli S, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroidresistant nephrotic syndrome. Nat Genet, 2000, 24: 349-354.
